JOSHUA MAKOWER
CIK 1235952 · last filed 2022-10-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$559.23M
Companies
18
Total Filings
46
Lifetime Open-Market Net
$218.01M
Filer Profile
Reported Address
1212 TERRA BELLA AVENUEMOUNTAIN VIEW, CA 94043
Related Filers
FOREST BASKETT — 5 joint filings, latest 2021-07-30
Anthony A. Florence Jr. — 5 joint filings, latest 2021-07-30
Mohamad Makhzoumi — 5 joint filings, latest 2021-07-30
NEA 15 GP, LLC — 5 joint filings, latest 2021-07-30
NEA Partners 15, L.P. — 5 joint filings, latest 2021-07-30
New Enterprise Associates 15, L.P. — 5 joint filings, latest 2021-07-30
SCOTT D SANDELL — 5 joint filings, latest 2021-07-30
Peter W. Sonsini — 5 joint filings, latest 2021-07-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Eargo, Inc. (EAR) Delisted | Director | 1,500 | $2.57 | $3.9K | $5.60M | 5 | 2022-10-14 |
| NeueHealth, Inc. (BHG) Delisted | 10%+ Owner | 278,608 | $16.35 | $4.56M | $35.00M | 1 | 2021-06-30 |
| GLUE | 10%+ Owner | 5,973,296 | $14.07 | $84.04M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 228 | $4.96 | $1.1K | $0 | 1 | 2021-06-10 |
| MRKR | 10%+ Owner | 1,071,428 | $1.15 | $1.23M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 645,106 | $8.16 | $5.26M | $3.96M | 3 | 2020-12-07 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 1,958,333 | $0.49 | $969.2K | $10.00M | 1 | 2020-09-22 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,000,533 | $4.00 | $8.00M | $4.00M | 1 | 2020-07-28 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 10,376,936 | $0.00 | $6.2K | $21.78M | 3 | 2020-07-28 |
| NKTX | 10%+ Owner | 522,639 | $2.91 | $1.52M | $12.00M | 1 | 2020-07-16 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 513,758 | $13.29 | $6.83M | $10.00M | 1 | 2020-07-01 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 3,952,958 | $15.00 | $59.29M | $24.62M | 16 | 2020-06-22 |
| TRVI | 10%+ Owner | 5,938,562 | $15.90 | $94.42M | $25.00M | 2 | 2020-04-13 |
| ARDX | 10%+ Owner | 3,082,186 | $3.58 | $11.03M | $23.33M | 4 | 2019-12-09 |
| MIRM | 10%+ Owner | 3,736,243 | $98.22 | $366.97M | $6.75M | 1 | 2019-07-24 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
Recent Filings · Page 3 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-25 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +2,857,142 | $10.00M | EDGAR |
| 2019-05-13 | TRVI | Mixed | +4,438,562 | $25.00M | EDGAR |
| 2019-05-09 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +1,136,704 | $1.23M | EDGAR |
| 2019-04-08 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +4,347,827 | $4.96M | EDGAR |
| 2019-02-19 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Buy (P) | +9,948,269 | $4.69M | EDGAR |
| 2018-12-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +500,000 | $774.4K | EDGAR |
| 2018-12-12 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +61,200 | $121.1K | EDGAR |
| 2018-12-10 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +170,400 | $338.4K | EDGAR |
| 2018-11-30 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +96,400 | $190.9K | EDGAR |
| 2018-11-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +170,000 | $336.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.